Swiss biopharmaceutical company Inthera nets $3.7 mln
Swiss biopharmaceutical company Inthera Bioscience has raised $3.7 million in funding. MS Ventures led the round with participation from Aglaia BioMedical Ventures, EVA Basel and Novo Seeds.
15 December 2015•2 mins read
